2008 annual financial data

XTL Biopharmaceuticals 2008 Financial results

Direct answer

Revenue was 5,940,000 USD.

Operating income was -9,591,000 USD and net income was -9,246,000 USD.
Operating cash flow was -10,578,000 USD.

Get free XTL Biopharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
5,940,000 USD
Operating income
-9,591,000 USD
Net income
-9,246,000 USD
Operating cash flow
-10,578,000 USD